Iron chelation therapy with deferiprone improves oxidative status and red blood cell quality and reduces redox-active iron in β-thalassemia/hemoglobin E patients

بواسطة Noppawan Phumala Morales, Supot Rodrat, Pannaree Piromkraipak, Paveena Yamanont, Kittiphong Paiboonsukwong, Suthat Fucharoen
منشور في 2022

Comparison of pharmacokinetics and urinary iron excretion of two single doses of deferiprone in β-Thalassemia/hemoglobin e patients

بواسطة Supot Rodrat, Pavena Yamanont, Jeeranut Tankanitlert, Udom Chantraraksri, Suthat Fucharoen, Noppawan Phumala Morales
منشور في 2018